Bisphosphonates may cause poorer survival rate in women with early stage breast cancer: Study

Links shared publicly online about this topic.

1,112
total visits

Bisphosphonates may cause poorer survival rate in women with early stage breast cancer: Study

Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented preliminary data that shows nitrogen-containing bisphosphonates, therapeutic agents used to promote bone health and inhibit resorption, may cause a slightly poorer survival rate in post-menopausal women with early stage breast cancer who take them for their anti-osteoporosis properties.

View full resource at news-medical.net

Tags: Cancer, Breast Cancer, Bone, Osteoporosis, Women's Health, Scientist